FI79101B - Foerfarande foer framstaellning av ett nytt terapeutiskt anvaendbart 1-(2,3,4-trimetoxibensyl)-4-/bis(4- fluorfenyl)metyl/piperazin. - Google Patents
Foerfarande foer framstaellning av ett nytt terapeutiskt anvaendbart 1-(2,3,4-trimetoxibensyl)-4-/bis(4- fluorfenyl)metyl/piperazin. Download PDFInfo
- Publication number
- FI79101B FI79101B FI851217A FI851217A FI79101B FI 79101 B FI79101 B FI 79101B FI 851217 A FI851217 A FI 851217A FI 851217 A FI851217 A FI 851217A FI 79101 B FI79101 B FI 79101B
- Authority
- FI
- Finland
- Prior art keywords
- compound
- piperazine
- methyl
- bis
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Claims (5)
1. Förfarande för framställning av ett terapeu-tiskt användbart 1-(2,3,4-trimetoxibensyl)-4-^bis(4-fluor-5 fenyl)metyl7piperazin med formeln (I) eller ett farmaceu-tiskt godtagbart syraadditionssalt därav, ^ F H,CO . , JJ 10 Ό.ui 15 kännetecknat därav, att man a) medelst reduktion kondenserar ett bensaldehyd-derivat med den följande allmänna formeln (II) h3C0
20. A (ID H3CO'^VA"Cho h3c6 med 4-^bis(4-fluorfenyl)metyl^piperazin med den följande allmänna formeln (III) fi^TF JJ /J /~\ / ^_f ( (III) ” o eller b) kondenserar ett bensylhalogenidderivat med den följande allmänna formeln (IV)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6446484 | 1984-03-30 | ||
JP59064464A JPS60222472A (ja) | 1984-03-30 | 1984-03-30 | 新規なピペラジン誘導体および該化合物を有効成分とする医薬組成物 |
Publications (4)
Publication Number | Publication Date |
---|---|
FI851217A0 FI851217A0 (fi) | 1985-03-26 |
FI851217L FI851217L (fi) | 1985-10-01 |
FI79101B true FI79101B (fi) | 1989-07-31 |
FI79101C FI79101C (sv) | 1989-11-10 |
Family
ID=13258978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI851217A FI79101C (sv) | 1984-03-30 | 1985-03-26 | Förfarande för framställning av ett nytt terapeutiskt användbart 1-(2, 3,4-trimetoxibensyl)-4-/bis(4-fluorfenyl)metyl/piperazin. |
Country Status (10)
Country | Link |
---|---|
US (1) | US4663325A (sv) |
EP (1) | EP0159566B1 (sv) |
JP (1) | JPS60222472A (sv) |
AT (1) | ATE31411T1 (sv) |
CA (1) | CA1248110A (sv) |
DE (1) | DE3561199D1 (sv) |
ES (3) | ES8702393A1 (sv) |
FI (1) | FI79101C (sv) |
GR (1) | GR850787B (sv) |
NO (1) | NO163185C (sv) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61161272A (ja) * | 1985-01-11 | 1986-07-21 | Kanebo Ltd | 新規なピペラジン誘導体および該化合物を有効成分とする医薬組成物 |
US4792553A (en) * | 1986-02-04 | 1988-12-20 | Terumo Kabushiki Kaisha | Diene derivatives and vasodilators containing the same |
FR2614021B1 (fr) * | 1987-04-14 | 1991-03-01 | Andre Buzas | Derives de la 1-((1,1-diphenyl)-1-alcenyl)-piperazine, procede d'obtention et compositions pharmaceutiques les contenant |
DE4108527A1 (de) * | 1991-03-15 | 1992-09-17 | Basf Ag | Neue 1-(4-cyano-4-aryl-cyclohexyl)piperazine, ihre herstellung und verwendung |
AU646926B2 (en) * | 1991-03-20 | 1994-03-10 | Duphar International Research B.V. | Alkylenedioxyphenyl ether derivatives having anti-ischaemic, memory enhancing and anti-convulsive activity |
KR960701033A (ko) * | 1993-12-08 | 1996-02-24 | 그레그 씨.브라운 | 효능있는 칼슘 길항 및 산화방지 활성을 모두 갖는 화합물, 및 세포보호제로서 그것의 사용방법(compounds having both potent calcium antagonist and antioxidant activity and use there of as cytoprotective agents) |
WO1999038515A1 (fr) * | 1998-01-29 | 1999-08-05 | Akzo Nobel N.V. | Agents ameliorant la circulation optique papillaire |
MXPA05001958A (es) | 2002-08-19 | 2005-04-28 | Pfizer Prod Inc | Terapia de combinacion para enfermedades hiperproliferativas. |
US7433519B2 (en) | 2003-04-04 | 2008-10-07 | Avid Technology, Inc. | Bitstream format for compressed image data |
US7403561B2 (en) | 2003-04-04 | 2008-07-22 | Avid Technology, Inc. | Fixed bit rate, intraframe compression and decompression of video |
WO2004093813A2 (en) * | 2003-04-22 | 2004-11-04 | Pharmacia Corporation | Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of pain, inflammation or inflammation mediated disorders |
WO2004093816A2 (en) * | 2003-04-22 | 2004-11-04 | Pharmacia Corporation | Compositions comprising a selective cox-2 inhibitor and a calcium modulating agent |
EA009646B1 (ru) * | 2003-05-30 | 2008-02-28 | Рэнбакси Лабораториз Лтд. | Замещённые производные пиррола и их применение в качестве ингибиторов hmg-coa |
US20050037063A1 (en) * | 2003-07-21 | 2005-02-17 | Bolton Anthony E. | Combined therapies |
EP1865945A4 (en) * | 2005-03-11 | 2008-05-21 | Hong Kong Nitric Oxide Ltd | TREATMENT COMBINATION FOR ENDOTHELIAL DISORDERS, ANGINA AND DIABETES |
US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
EP2351569B1 (en) | 2005-10-26 | 2012-08-22 | Asahi Kasei Pharma Corporation | Fasudil in combination therapies for the treatment of pulmonary arterial hypertension |
ATE551059T1 (de) | 2005-10-26 | 2012-04-15 | Asahi Kasei Pharma Corp | Fasudil in kombination mit bosentan zur behandlung von pulmonaler arterieller hypertonie |
AU2006313430B2 (en) * | 2005-11-08 | 2012-09-06 | Ranbaxy Laboratories Limited | Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt |
US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
TW200744583A (en) * | 2006-03-14 | 2007-12-16 | Ranbaxy Lab Ltd | Statin stabilizing dosage formulations |
MX2009000439A (es) * | 2006-07-14 | 2009-02-04 | Ranbaxy Lab Ltd | Formas polimorficas de un inhibidor de hmg-coa reductasa y usos de las mismas. |
CN101663262B (zh) | 2006-12-01 | 2014-03-26 | 百时美施贵宝公司 | 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物 |
CN101622243B (zh) | 2007-02-28 | 2013-12-04 | 旭化成制药株式会社 | 磺酰胺衍生物 |
WO2012037665A1 (en) | 2010-09-24 | 2012-03-29 | Oral Delivery Technology Ltd. | Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions |
CN102936233B (zh) * | 2012-11-16 | 2016-01-20 | 葛长乐 | 一种1-(二(4-氟苯基)甲基)-4-(2,3,4-三甲氧苯基)哌嗪二盐酸盐晶型 |
CN105143203A (zh) | 2013-04-17 | 2015-12-09 | 辉瑞大药厂 | 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物 |
WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
WO2017069343A1 (ko) * | 2015-10-20 | 2017-04-27 | 한국표준과학연구원 | 위치조절이 용이한 전자현미경용 전자총 및 이를 포함하는 전자현미경 |
CN109666008A (zh) * | 2018-12-31 | 2019-04-23 | 辰欣药业股份有限公司 | 一种盐酸洛美利嗪的合成方法 |
CN113574055B (zh) | 2019-01-18 | 2024-07-23 | 阿斯利康(瑞典)有限公司 | Pcsk9抑制剂及其使用方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB705979A (en) * | 1951-03-22 | 1954-03-24 | Henri Morren | 1.4-aralkyl piperazines and process for the preparation thereof |
FR1312427A (fr) * | 1961-04-12 | 1962-12-21 | Science Union Et Compagnie Soc | Nouveaux dérivés de la pipérazine et leurs préparations |
FR1303080A (fr) * | 1961-07-25 | 1962-09-07 | Science Union Et Compagnie Soc | Pipérazines disubstituées |
NL7306771A (sv) * | 1972-06-02 | 1973-12-04 | ||
DE2900810A1 (de) * | 1979-01-11 | 1980-07-24 | Cassella Ag | Substituierte n-benzhydryl-n'-p- hydroxybenzyl-piperazine und verfahren zu ihrer herstellung |
GB8320701D0 (en) * | 1983-08-01 | 1983-09-01 | Wellcome Found | Chemotherapeutic agent |
-
1984
- 1984-03-30 JP JP59064464A patent/JPS60222472A/ja active Granted
-
1985
- 1985-03-25 US US06/715,813 patent/US4663325A/en not_active Expired - Lifetime
- 1985-03-26 FI FI851217A patent/FI79101C/sv not_active IP Right Cessation
- 1985-03-26 CA CA000477468A patent/CA1248110A/en not_active Expired
- 1985-03-27 AT AT85103707T patent/ATE31411T1/de not_active IP Right Cessation
- 1985-03-27 EP EP85103707A patent/EP0159566B1/en not_active Expired
- 1985-03-27 DE DE8585103707T patent/DE3561199D1/de not_active Expired
- 1985-03-28 GR GR850787A patent/GR850787B/el unknown
- 1985-03-29 ES ES541728A patent/ES8702393A1/es not_active Expired
- 1985-03-29 NO NO851298A patent/NO163185C/no not_active IP Right Cessation
-
1986
- 1986-07-29 ES ES556980A patent/ES8801236A1/es not_active Expired
- 1986-07-29 ES ES556981A patent/ES8801237A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
NO851298L (no) | 1985-10-01 |
EP0159566A1 (en) | 1985-10-30 |
ES8702393A1 (es) | 1987-01-01 |
CA1248110A (en) | 1989-01-03 |
ES556981A0 (es) | 1988-01-01 |
JPS60222472A (ja) | 1985-11-07 |
DE3561199D1 (en) | 1988-01-28 |
NO163185C (no) | 1990-04-18 |
FI851217L (fi) | 1985-10-01 |
US4663325A (en) | 1987-05-05 |
GR850787B (sv) | 1985-11-25 |
ES8801236A1 (es) | 1988-01-01 |
EP0159566B1 (en) | 1987-12-16 |
ES8801237A1 (es) | 1988-01-01 |
JPH0313232B2 (sv) | 1991-02-22 |
ES541728A0 (es) | 1987-01-01 |
ES556980A0 (es) | 1988-01-01 |
FI851217A0 (fi) | 1985-03-26 |
ATE31411T1 (de) | 1988-01-15 |
FI79101C (sv) | 1989-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI79101B (fi) | Foerfarande foer framstaellning av ett nytt terapeutiskt anvaendbart 1-(2,3,4-trimetoxibensyl)-4-/bis(4- fluorfenyl)metyl/piperazin. | |
CA1199918A (en) | 2-¬4-(diphenylmethyl)-1-piperazinyl|-acetic acids and their amides | |
US3299067A (en) | 2-[1'-(benzyl and phenyl)-4'-piperazinyl]-pyrimidine derivatives | |
PL92131B1 (sv) | ||
US4711899A (en) | 2-(4-benzoyl-1-piperidyl)-1-phenylalkanol derivatives | |
JPH0647586B2 (ja) | 1−ヘテロアリ−ル−4−〔(2.5−ピロリジンジオン−1−イル)アルキル〕ピペラジン誘導体 | |
CA1238636A (en) | Piperazine derivatives and their acid addition salts | |
US3272824A (en) | 4-amino-6, 7-di(lower) alkoxyquinolines | |
FI84827C (sv) | Förfarande för framställning av terapeutiskt användbara pyridinderivat | |
US5852019A (en) | Pyrimidinylpyrazole derivatives | |
WO1984000489A1 (en) | Heteroaryl substituted aminomethyl benzene derivatives, compositions and use | |
FI77224B (fi) | Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara aminopropanolderivat av 2-hydroxi- -fenylpropiofenoner. | |
LV10716B (en) | Novel derivatives of triazolopyridine and triazoloquinoline aminoalkylthio compounds, methods for preparation thereof, medicinal preparations containing same, their use as analgetics | |
Boissier et al. | Synthesis and pharmacological study of new piperazine derivatives. I. Benzylpiperazines | |
PT95902B (pt) | Processo para a preparacao de derivados de piridazina uteis como ligandos dos receptores colinergicos | |
IL90309A (en) | History of 6-Phenyl-3-) Piperazinylacil (- H, 3H (- PHRHNHSHBSHUI, VFB1) -2,4 T I, U T FAHRH RUEJU T VNFHKHO TU T I | |
US2820817A (en) | Oxygenated indan compounds and method of making the same | |
NZ234789A (en) | Piperazinyl substituted pyridine and oxazolo(4,5-b)pyridine derivatives and pharmaceutical compositions thereof | |
CA1185604A (en) | Phenethanolamine derivatives | |
HU196196B (en) | Process for producing new benzhydryl-piperazine derivatives and pharmaceuticals comprising the compounds | |
US4005212A (en) | Imidazo[2,1-b]thiazole derivatives | |
FI63566C (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara dibenso(d g)(1,3,6)dioxazocin-derivat och av deras fysiologiskt godtagbara syraadditionssalter | |
US4607040A (en) | Quinoline derivatives which are 5-hydroxytryptamine antagonists | |
PT617027E (pt) | Novos compostos de n-benzil-piperazina processo para a sua preparacao e as composicoes farmaceuticas que os contem | |
US3925384A (en) | 2-Amino-4,5-dihydro-4-arylindeno pyrimidines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Owner name: AKZO NOBEL N.V. |
|
MA | Patent expired |